Review | Cardiovascular complications of immune checkpoint inhibitors for cancer.
6 Sep, 2022 | 14:20h | UTCCardiovascular complications of immune checkpoint inhibitors for cancer – European Heart Journal
Related:
Cardiotoxicity of immune checkpoint inhibitors – ESMO Open
Cardiotoxicity from immune checkpoint inhibitors – IJC Heart & Vasculature
Commentary on Twitter
Must read state-of-the-art review: Cardiovascular complications of immune checkpoint inhibitors for cancer https://t.co/0lr7g6s8g0
#EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/jORaTzP7GD— European Society of Cardiology Journals (@ESC_Journals) September 5, 2022